Future research is needed to clarify the factors that trigger the accumulation of proinflammatory Th1 cells and promote NASH progression and reconcile them with the data showing a loss of CD4 T cells during disease. The gene discussed is CD4; the disease is metabolic dysfunction-associated steatohepatitis.